National Health Investors, Inc. (NHI)
USD 68.9
(-4.0%)
USD 68.9
(-4.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 319.83 Million | 278.19 Million | 298.71 Million | 332.81 Million | 318.08 Million | 294.61 Million |
| Cost of Revenue | 11.51 Million | 9.78 Million | 11.63 Million | 9.65 Million | 5.79 Million | 1.16 Million |
| Gross Profit | 308.32 Million | 268.4 Million | 287.07 Million | 323.15 Million | 312.28 Million | 293.44 Million |
| Operating Expenses | 129.53 Million | 125.24 Million | 153.69 Million | 99.23 Million | 92.27 Million | 85.37 Million |
| Selling, General and Administrative Expenses | 19.82 Million | 25.32 Million | 19.33 Million | 14.55 Million | 13.9 Million | 12.85 Million |
| Research and Development Expenses | - | 0.23 | 0.38 | 0.57 | 0.50 | 0.52 |
| Other Expenses | 109.7 Million | 99.91 Million | 134.35 Million | 84.67 Million | 78.36 Million | 71.34 Million |
| Cost and Expenses | 141.04 Million | 135.02 Million | 165.32 Million | 108.88 Million | 98.07 Million | 85.37 Million |
| Operating Income | 178.79 Million | 81.11 Million | 132.19 Million | 220.8 Million | 220.01 Million | 209.24 Million |
| Interest Expense | 55.51 Million | 44.91 Million | 50.81 Million | 52.88 Million | 56.29 Million | 49.05 Million |
| Income Tax Expense | - | 42.44 Million | 49.77 Million | 49.94 Million | 56.29 Million | -9.16 Million |
| Earnings before Tax | 134.38 Million | 65.5 Million | 111.96 Million | 185.31 Million | 160.44 Million | 154.33 Million |
| Net Income | 135.65 Million | 23.06 Million | 62.18 Million | 135.37 Million | 104.15 Million | 154.33 Million |
| Earnings Per Share Basic | 3.13 | 0.52 | 1.36 | 3.03 | 2.40 | 3.68 |
| Earnings Per Share Diluted | 3.13 | 0.51 | 1.36 | 3.03 | 2.38 | 3.67 |
| Weighted Average Shares Outstanding | 43.38 Million | 44.77 Million | 45.71 Million | 44.69 Million | 43.41 Million | 41.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.38 Million | 44.79 Million | 45.72 Million | 44.69 Million | 43.7 Million | 42.09 Million |
| Gross Margin | 0.96 | 0.96 | 0.96 | 0.97 | 0.98 | 1.00 |
| EBIT Margin | 0.78 | 0.55 | 0.71 | 0.91 | 0.93 | 0.95 |
| Profit Margin | 0.42 | 0.08 | 0.21 | 0.41 | 0.33 | 0.52 |
| EBITDA | 249.02 Million | 151.99 Million | 212.98 Million | 303.95 Million | 296.82 Million | 280.59 Million |
| Earnings Before Tax Margin | 0.56 | 0.29 | 0.44 | 0.66 | 0.69 | 0.71 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 69.17 Million | 85.69 Million | 82.23 Million | 79.46 Million | 319.83 Million | 80.1 Million |
| Cost of Revenue | 2.88 Million | 31.45 Million | 31.27 Million | 2.77 Million | 11.51 Million | 2.9 Million |
| Gross Profit | 66.28 Million | 54.24 Million | 50.96 Million | 76.69 Million | 308.32 Million | 77.19 Million |
| Operating Expenses | 7.85 Million | 33 Million | 5.45 Million | 31.94 Million | 129.53 Million | 32.05 Million |
| Selling, General and Administrative Expenses | 4.81 Million | 5.03 Million | 5.87 Million | 5.06 Million | - | 4.49 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 3.04 Million | -1.1 Million | -5.45 Million | 1.72 Million | 202 Thousand | -1.75 Million |
| Cost and Expenses | 10.74 Million | 36.36 Million | 36.73 Million | 34.72 Million | 141.04 Million | 34.96 Million |
| Operating Income | 58.42 Million | 49.32 Million | 45.5 Million | 46.3 Million | 20 Thousand | 202 Thousand |
| Interest Expense | - | 13.98 Million | 14.04 Million | 14.13 Million | 55.51 Million | 14.36 Million |
| Income Tax Expense | - | -304 Thousand | -290 Thousand | 16.16 Million | 55.07 Million | 12.29 Million |
| Earnings before Tax | 28.51 Million | 34.95 Million | 30.65 Million | 31.79 Million | 134.45 Million | 29.03 Million |
| Net Income | 28.51 Million | 35.25 Million | 30.94 Million | 32.04 Million | 135.65 Million | 29.34 Million |
| Earnings Per Share Basic | 0.66 | 0.81 | 0.71 | 0.74 | - | 0.68 |
| Earnings Per Share Diluted | 0.65 | 0.81 | 0.71 | 0.74 | - | 0.68 |
| Weighted Average Shares Outstanding | 43.47 Million | 43.39 Million | 43.38 Million | 43.38 Million | 43.38 Million | 43.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.98 Million | 43.56 Million | 43.42 Million | 43.38 Million | 43.38 Million | 43.38 Million |
| Gross Margin | 0.96 | 0.63 | 0.62 | 0.97 | 0.96 | 0.96 |
| EBIT Margin | 0.84 | 0.79 | 0.78 | 0.80 | - | 0.75 |
| Profit Margin | 0.41 | 0.41 | 0.38 | 0.40 | 0.42 | 0.37 |
| EBITDA | 58.42 Million | 67.53 Million | 63.73 Million | 63.42 Million | - | 60.17 Million |
| Earnings Before Tax Margin | 0.84 | 0.58 | 0.55 | 0.58 | 0.00 | 0.00 |
RAILTEL
POLYMED
WYNMF
002962
ORRYY
CHI